Connection

ERIC BOERWINKLE to Repressor Proteins

This is a "connection" page, showing publications ERIC BOERWINKLE has written about Repressor Proteins.
Connection Strength

0.451
  1. Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome. Am J Med Genet A. 2021 01; 185(1):119-133.
    View in: PubMed
    Score: 0.118
  2. Identification of likely pathogenic and known variants in TSPEAR, LAMB3, BCOR, and WNT10A in four Turkish families with tooth agenesis. Hum Genet. 2018 Sep; 137(9):689-703.
    View in: PubMed
    Score: 0.101
  3. Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis. Am J Hum Genet. 2016 08 04; 99(2):481-8.
    View in: PubMed
    Score: 0.088
  4. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. Nature. 2023 Apr; 616(7958):755-763.
    View in: PubMed
    Score: 0.035
  5. Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI. Brain. 2023 02 13; 146(2):492-506.
    View in: PubMed
    Score: 0.035
  6. Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. J Clin Invest. 2015 Feb; 125(2):636-51.
    View in: PubMed
    Score: 0.020
  7. Gene-specific function prediction for non-synonymous mutations in monogenic diabetes genes. PLoS One. 2014; 9(8):e104452.
    View in: PubMed
    Score: 0.019
  8. Genome-wide association study of retinopathy in individuals without diabetes. PLoS One. 2013; 8(2):e54232.
    View in: PubMed
    Score: 0.017
  9. FTO genotype is associated with phenotypic variability of body mass index. Nature. 2012 Oct 11; 490(7419):267-72.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.